latest news on compounded tirzepatide versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter Thursday. Following laboratory testing, the drugmaker said Compounded Tirzepatide With B6 (Pyridoxine)

SURMOUNT-1 data showed 22.5% average body weight reduction at this dose over 72 weeks

However, there are times when professional guidance is necessary

If patients experience intolerable side effects at a given dose, maintaining the current dose for an additional 4 weeks or temporarily reducing the dose may improve tolerance before attempting further escalation

Instead of jumping in 2.5mg increments, microdosing uses smaller steps, often 1mg or 1.25mg, over longer intervals

Retatrutide Phase 2 and Phase 3: breaking records Retatrutide entered the picture with Phase 2 trial data that immediately captured attention

The FDA label and population PK analysis confirm that bioavailability is the same whether you inject in your abdomen, thigh, or upper arm